CRSP News and Press, CRISPR Therapeutics AG From 11/25/23

2023-11-25 03:39:49 ET Summary Gene editing, also known as genome editing, allows scientists to modify the DNA of organisms using biotechnological techniques. CRISPR-Cas9 is the most widely used gene editing technology, known for its simplicity and versatility. Major publicly ...

2023-11-21 15:13:40 ET More on Beam, CRISPR, etc. Intellia: Soon-To-Be Enrollment Completion Brings About Catalysts In 2024 Editas Medicine, Inc. (EDIT) Presents at Stifel 2023 Healthcare Conference (Transcript) Beam Therapeutics: Sale Of Rights To Verve's In Vivo Ca...

2023-11-19 05:30:00 ET All eyes have been on CRISPR Therapeutics (NASDAQ: CRSP) in recent times because the biotech company has reached a key moment. CRISPR Therapeutics and partner Vertex Pharmaceuticals are awaiting regulatory decisions on exa-cel, their candidate to treat blo...

2023-11-18 06:49:00 ET Most, if not all, of the market's current mega-cap stocks started out much smaller. Investors who spotted their potential early had opportunities to make fortunes over time. Which smaller stocks today could be monsters in the making? Here's why three Motley Fool c...

2023-11-17 11:12:15 ET Shares of CRISPR Therapeutics (NASDAQ: CRSP) were jumping 10.1% higher as of 10:58 a.m. ET on Friday. The solid move followed Thursday's gain of more than 8%. There's a good reason for this accelerated momentum for the gene-editing stock . On Thursday,...

2023-11-16 15:54:01 ET More on CRISPR Therapeutics CRISPR Therapeutics: Positive Exa-Cel AdCom Opens Door For Historic Approval Risk And Reward: Evaluating Crispr's Exa-Cel For Sickle Cell Crispr: Upcoming Catalysts, Plenty Of Cash And Strong Partnerships Make It A B...

2023-11-16 06:00:00 ET Crispr Therapeutics (NASDAQ: CRSP) stock price will be in the spotlight on Thursday after the company made a major breakthrough in the UK. The shares surged to a multi-month high of $60 in the pre-market session. At its peak, they were up by about 60% from the low...

2023-11-16 05:43:04 ET More on CRISPR Therapeutics, Vertex Pharmaceuticals, etc. Vertex Pharmaceuticals Incorporated (VRTX) Jefferies Global Healthcare Conference Call Transcript Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Biopharma Conference (Transcript) ...

2023-11-16 05:30:00 ET CRISPR Therapeutics (NASDAQ: CRSP) has reached a very exciting point in its story. The biotech company that specializes in gene editing is awaiting regulatory decisions on what could become its first commercialized product. The U.S. Food and Drug Administratio...

2023-11-16 05:28:02 ET Related stories Palo Alto Networks Q1'FY24 Review: Billings Weakness Creates Buying Opportunity Palo Alto Networks, Inc. (PANW) Q1 2024 Earnings Call Transcript Maxeon Solar Technologies Ltd (MAXN) Q3 2023 Earnings Call Transcript Cisco...